Developing antigen-specific therapies in multiple sclerosis: a tale of Tantalus or Ulysses?

Author: van Noort J.M.  

Publisher: Informa Healthcare

ISSN: 1354-3784

Source: Expert Opinion on Investigational Drugs, Vol.8, Iss.10, 1999-10, pp. : 1537-1550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract